Liver transplantation and non-alcoholic fatty liver disease. - Wikidata - wikimedia - TriplyDB

Liver transplantation and non-alcoholic fatty liver disease.

Liver transplantation and non-alcoholic fatty liver disease.

http://www.wikidata.org/entity/Q34499022

about

New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article Sun Exposure and Its Effects on Human Health: Mechanisms through Which Sun Exposure Could Reduce the Risk of Developing Obesity and Cardiometabolic Dysfunction Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto Experience Adverse effects of chronic exposure to nonylphenol on non-alcoholic fatty liver disease in male rats.Clinical impact of alcohol-related cirrhosis in the next decade: estimates based on current epidemiological trends in the United States.Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease Hepatic PPARγ Is Not Essential for the Rapid Development of Steatosis After Loss of Hepatic GH Signaling, in Adult Male Mice Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor One-time injection of AAV8 encoding urocortin 2 provides long-term resolution of insulin resistance Albumin Binding Function: The Potential Earliest Indicator for Liver Function Damage.Polyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial.Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation.Adipocytokines and hepatic fibrosis.Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.Traffic-related air pollution associations with cytokeratin-18, a marker of hepatocellular apoptosis, in an overweight and obese paediatric population.The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.Early life programming and the risk of non-alcoholic fatty liver disease.Bi-directional analysis between fatty liver and cardiovascular disease risk factors.Recurrence of graft steatosis after liver transplantation for cryptogenic cirrhosis in recently commenced liver transplant program.Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy.Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease.PNPLA3 I148M variant affects non-alcoholic fatty liver disease in liver transplant recipients.The hepatic circadian clock fine-tunes the lipogenic response to feeding through RORα/γ.PKCδ silencing alleviates saturated fatty acid induced ER stress by enhancing SERCA activity.Nonalcoholic Fatty Liver Disease Is Not Associated with Thyroid Hormone Levels and Hypothyroidism: A Systematic Review and Meta-Analysis.Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice.Transporter-mediated Alterations in Patients with NASH Increase Systemic and Hepatic Exposure to an OATP and MRP2 Substrate.A diet containing a high- versus low-daidzein level does not protect against liver steatosis in the obese Zucker rat model.Primary non-function is frequently associated with fatty liver allografts and high mortality after re-transplantation.Resolution of donor non-alcoholic fatty liver disease following liver transplantation.Long-term administration of tacrolimus and everolimus prevents high cholesterol-high fructose-induced steatosis in C57BL/6J mice by inhibiting de-novo lipogenesis.Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD).A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice.Non-Alcoholic Fatty Liver Disease.Protective and therapeutic effects of Crataegus aronia in non-alcoholic fatty liver disease.Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis.Quantitative Assessment of Liver Steatosis and Affected Pathways with Molecular Imaging and Proteomic Profiling.Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet-induced mouse model of nonalcoholic steatohepatitis.

P2860

Q28070168-8B16124C-60F9-4E70-97AF-FC85334BCD57 Q28073380-666A41E1-EDD3-4FEF-BD13-B81547466914 Q30234444-A8D4E4E3-6300-4D84-A0A2-E6520F35F22A Q33779040-13355A74-B4E4-41C3-AA5C-B78A6A28128A Q33883845-1B4E4882-3B66-4C82-B64C-7470C8783E63 Q36219877-25BA6566-ED4B-4866-9B13-D5B0DD7EBC14 Q36818384-C728673E-AB47-4102-A6B2-F80E2DBCB0A4 Q36911537-196123F4-E911-4768-AF0E-B5A9F2DFFF83 Q37239135-199D77D4-D931-4333-8E07-343D66BF26F1 Q37277047-71A21E3B-6CE2-4FBC-A470-16BA6E9C3228 Q37557655-E311D2BB-9B1B-4D49-8AA5-D2E2C517EC97 Q37641048-EA16380E-B145-43FA-9789-2D07AD23E121 Q37691781-8A9A07E0-5085-4852-8EE4-655399FB510C Q38346026-2FD95A85-90FB-4849-9D32-38F405356962 Q38430909-5CC5A41B-5134-4797-B3B7-5614FE2368A1 Q38668556-714291A8-AAE4-4550-9244-298DE03F3D79 Q38676257-3DFD96E3-697A-4B59-A14B-BBEE24478F26 Q39006023-75AD0AE2-447C-4302-B2AF-AEA49CCE442E Q40546061-955A281E-79DF-4F40-A6E0-BE45208961C8 Q40689251-38F0B3EC-A41E-4843-B3F8-7C00207253CA Q42327233-A0683184-B3B1-43C2-B267-458F6D8C6D42 Q42368231-2C44E88B-9AA1-443D-8FF3-02D6046AF8F2 Q42762323-3FD97610-89AA-4B50-A0FD-31F96C454F8B Q47095631-BAD7A1F9-7C05-46D5-9AA1-A24AB5856BEC Q47127745-931D0DD9-7415-4E1B-943D-5654AB00A7DC Q47134584-75C7757A-5975-414A-B60A-2334A69E7D88 Q47152443-4D4E179B-AF54-4EC0-92AB-ED64F05D8F90 Q47260944-936B352E-98F9-48D0-8541-D2A32528AC39 Q47845194-2BB5CE81-C8E4-4137-A0A1-B57D9A751FE1 Q48154190-1BD9F538-ED61-400A-8118-DA757354FA6B Q48245357-F4558712-80B4-4995-81A6-6F182071CA8C Q49438485-3833A910-5911-47FB-9591-E1F2EA4BDF3E Q49959126-A879D0A1-BADB-47F5-B37C-6F5D55AA6BA6 Q50222903-56F46690-0C57-40F3-BD93-8285B0650C41 Q50957769-68CFDA80-1838-4557-A747-44069FF2CD7B Q51636759-E07B313D-1DDF-4B67-BBAF-D3E185BEA8FC Q52584505-699F98DF-70D0-4344-8981-582045F808DE Q52651775-4DB2D711-FC15-48E7-8C1F-274F8FF7B377 Q52730229-7727EB95-DDDD-422D-A4D4-F081723E66F0 Q55114119-D37BE110-BC84-4D7C-A2AB-559E8E911DDD

P2860

Liver transplantation and non-alcoholic fatty liver disease.

http://www.wikidata.org/entity/Q34499022

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Liver transplantation and non-alcoholic fatty liver disease.

@ast

Liver transplantation and non-alcoholic fatty liver disease.

@en

Liver transplantation and non-alcoholic fatty liver disease.

@nl

type

label

Liver transplantation and non-alcoholic fatty liver disease.

@ast

Liver transplantation and non-alcoholic fatty liver disease.

@en

Liver transplantation and non-alcoholic fatty liver disease.

@nl

prefLabel

Liver transplantation and non-alcoholic fatty liver disease.

@ast

Liver transplantation and non-alcoholic fatty liver disease.

@en

Liver transplantation and non-alcoholic fatty liver disease.

@nl

P1433

Q34499022-FD26347A-AF69-45EA-ADF0-30C7B1FC8EC8

P1476

Q34499022-10FACE4A-C719-460A-A20C-781116A01B5D

P2093

Q34499022-5C6861E7-8D67-41C9-AD7A-479E1C952E03

P2860

Q34499022-043E5032-DA09-4B3C-B137-4BBF1CA2FB9E

Q34499022-068EC5B6-1FC7-49CF-BB1F-0A1D7B4A314F

Q34499022-09316E4A-85D7-4581-AB9B-532F5F015C29

Q34499022-0D4496FD-BD35-43DF-B90F-DE0FAE1A5CCC

Q34499022-14134BBB-EDE9-449F-9F00-B1CF61940F48

Q34499022-161046F2-ACB7-49FF-8EFB-3C1265CE80FF

Q34499022-18FD5660-6ED0-469C-B79A-60DEFEDE1F47

Q34499022-1D071CC3-939D-49C5-99AE-8B42A948DCDA

Q34499022-3756BDBE-7A44-45F3-94FC-C5CCAEEBCB6B

Q34499022-395CFD8C-03F7-4A3C-A434-53A3D631C2C5

P304

Q34499022-0B2ACD73-4331-4FFF-8199-FE9C7002195F

P31

Q34499022-0BDFE331-5426-47E3-AC68-9595B4951C7C

P356

Q34499022-766CD8F8-AA66-4367-AFD8-171402D25FCD

P407

Q34499022-B37109EF-0573-40CE-B2D5-BC8B89ACD3D7

P433

Q34499022-B21099A1-17FC-4F91-B1AF-D6D6C73A1C98

P478

Q34499022-5BB8C06C-209F-4E6F-88DD-EF1163239B94

P50

Q34499022-C7208CFE-4C79-48F9-99C5-D027E8462A8D

P577

Q34499022-27181C8A-9D01-4F03-9EE7-1BB9CA7FB594

P5875

Q34499022-046D2148-55FA-4238-B23A-919DDCC5F8D5

P698

Q34499022-5ECD8C5B-8743-4A5F-BF82-1FFD62A94D6C

P921

Q34499022-13DD50A2-7A9D-4D2E-85D8-E32248767CB8

P932

Q34499022-76E71755-57A1-4E2E-9C88-31CFDC3B8FB0

P356

WJG.V20.I42.15532

P1433

World Journal of Gastroenterology

P1476

Liver transplantation and non-alcoholic fatty liver disease.

@en

P2093

Eberhard L Renner

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.

The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis.

The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis.

The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes

Nonalcoholic fatty liver disease: from steatosis to cirrhosis.

Natural history of nonalcoholic steatohepatitis.

Pathophysiology of nonalcoholic steatohepatitis.

P304

15532-15538

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I42.15532

http://www.w3.org/2001/XMLSchema#string

P407

P433

42

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268450857

http://www.w3.org/2001/XMLSchema#string

P698

25400437

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation

P932

4229518

http://www.w3.org/2001/XMLSchema#string